SPDR S&P Biotech ETF trailing returns
SPDR S&P Biotech ETF's 10-year return is +9.4% a year (CAGR) (+145.7% cumulative). How SPDR S&P Biotech ETF (XBI) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -3.6% | +0.0% | -3.6% | — |
| 5 days | -6.1% | +0.0% | -6.1% | -6.1%Oct 16 |
| 1 month | -6.4% | +0.0% | -6.4% | -10.8%Oct 16 |
| YTD | +18.4% | +0.1% | +18.5% | -14.9%Oct 16 |
| 1 year | +33.7% | +0.6% | +34.3% | -14.9%Oct 2026 |
| 5 years | +2.9% | +0.1% | +3.0%+16.1% | -53.2%May 2022 |
| 10 years | +9.3% | +0.2% | +9.4%+145.7% | -63.9%May 2022 |
| 20 years | +11.5% | +0.2% | +11.7%+811.3% | -63.9%May 2022 |
| Since inception (2006) | +11.1% | +0.2% | +11.2%+807.2% | -63.9%May 2022 |
Growth of XBI#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+3.0%/year · +16.1%
- 10 years+9.4%/year · +145.7%
- 20 years+11.7%/year · +811.3%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in XBI's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is SPDR S&P Biotech ETF's 10-year return?
- Over the last 10 years, SPDR S&P Biotech ETF (XBI) returned about +9.4% a year annualized (+145.7% cumulative total return).
- What is SPDR S&P Biotech ETF's 20-year annualized return?
- Over the last 20 years, SPDR S&P Biotech ETF (XBI) compounded at about +11.7% a year (+811.3% cumulative).
- What is SPDR S&P Biotech ETF's return since inception?
- Since 2006, SPDR S&P Biotech ETF (XBI) has compounded at about +11.2% a year — +807.2% in total.